Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients

Journal of Hepatology

Volumn 56, Issue 2, 2012, Pages 313-319

  Thompson, Alexander J ^a   Clark, Paul J ^a   Singh, Abanish ^b   Ge, Dongliang ^b   Fellay, Jacques ^b   Zhu, Mingfu ^b   Zhu, Qianqian ^b   Urban, Thomas J ^b   Patel, Keyur ^a   Tillmann, Hans L ^a   Naggie, Susanna ^a   Afdhal, Nezam H ^c   Jacobson, Ira M ^d   Esteban, Rafael ^e   Poordad, Fred ^f   Lawitz, Eric J ^g   McCone, Jonathan ^h   Shiffman, Mitchell L ⁱ   Galler, Greg W ^j   King, John W ^k   Kwo, Paul Y ^l   Shianna, Kevin V ^b   Noviello, Stephanie ^m   Pedicone, Lisa D ^m   Brass, Clifford A ^m   Albrecht, Janice K ^m   Sulkowski, Mark S ⁿ   Goldstein, David B ^b   McHutchison, John G ^a   Muir, Andrew J ^a   more..

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g Alamo Medical Research   (United States)

^h Mt Vernon Endoscopy Center   (United States)

ⁱ Liver Institute of Virginia   (United States)

^j Kelsey Research Foundation   (United States)

^k LOUISIANA STATE UNIVERSITY   (United States)

^l INDIANA UNIVERSITY   (United States)

^m Schering Plough Research Institute (Now Merck Inc)   (United States)

ⁿ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

GWAS; Hepatitis C; IL28B; ITPA; Neutropenia; Thrombocytopenia

Indexed keywords

HEMOGLOBIN; INOSINE TRIPHOSPHATE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ANEMIA; ARTICLE; BASOPHIL; EOSINOPHIL COUNT; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LEUKOPENIA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPENIA; NEUTROPHIL COUNT; PATIENT COMPLIANCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOSIS; TREATMENT RESPONSE;

ADULT; ANTIVIRAL AGENTS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LEUKOPENIA; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NEUTROPENIA; POLYETHYLENE GLYCOLS; POLYMORPHISM, SINGLE NUCLEOTIDE; PYROPHOSPHATASES; RECOMBINANT PROTEINS; RIBAVIRIN; THROMBOCYTOPENIA;

EID: 84855974385     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.04.021     Document Type: Article

References (36)

1. D. Lavanchy The global burden of hepatitis C Liver Int 29 2009 74 81
2. M.W. Fried, M.L. Shiffman, K.R. Reddy, C. Smith, G. Marinos, and F.L. Goncales Jr. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975 982
3. M.P. Manns, J.G. McHutchison, S.C. Gordon, V.K. Rustgi, M. Shiffman, and R. Reindollar Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 2001 958 965 (Pubitemid 32913521)
4. J.G. McHutchison, M. Manns, K. Patel, T. Poynard, K.L. Lindsay, and C. Trepo Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C Gastroenterology 123 2002 1061 1069
5. H.L. Tillmann, K. Patel, and J.G. McHutchison Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis C Curr Gastroenterol Rep 11 2009 5 14
6. T.B. Haddy, S.R. Rana, and O. Castro Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med 133 1999 15 22 (Pubitemid 29032412)
7. D. Reich, M.A. Nalls, W.H. Kao, E.L. Akylbekova, A. Tandon, and N. Patterson Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene PLoS Genet 5 2009 e1000360
8. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and T.J. Urban Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
9. Thompson AJ, Muir A, Sulkowski M, et al. IL28B polymorphism improves viral kinetics and is the strongest pre-treatment predictor of SVR in HCV-1 patients gastroenterology 2010 [Epub ahead of print].
10. V. Suppiah, M. Moldovan, G. Ahlenstiel, T. Berg, M. Weltman, and M.L. Abate IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 2009 1100 1104
11. Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, and N. Sakamoto Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
12. J. Fellay, A.J. Thompson, D. Ge, C.E. Gumbs, T.J. Urban, and K.V. Shianna ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C Nature 464 2010 405 408
13. A.J. Thompson, J. Fellay, K. Patel, H.L. Tillmann, S. Naggie, and D. Ge Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction Gastroenterology. 139 2010 1181 1189
14. Y. Hitomi, E.T. Cirulli, J. Fellay, J.G. McHutchison, A.J. Thompson, and C.E. Gumbs Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by restoring adenylosuccinate synthase function Gastroenterology 140 2011 1314 1321
15. J.G. McHutchison, E.J. Lawitz, M.L. Shiffman, A.J. Muir, G.W. Galler, and J. McCone Peginterferon Alfa-2b or Alfa-2a with ribavirin for treatment of hepatitis C infection N Engl J Med 361 2009 580 593
16. A.J. Muir, J.D. Bornstein, and P.G. Killenberg Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites N Engl J Med 350 2004 2265 2271 (Pubitemid 38669209)
17. D.L. Thomas, C.L. Thio, M.P. Martin, Y. Qi, D. Ge, and C. O'Huigin Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
18. S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, and D. Bender PLINK: a tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575 (Pubitemid 47330214)
19. M.C. Whitlock Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach J Evol Biol 18 2005 1368 1373 (Pubitemid 41725687)
20. A.L. Price, N.J. Patterson, R.M. Plenge, M.E. Weinblatt, N.A. Shadick, and D. Reich Principal components analysis corrects for stratification in genome-wide association studies Nat Genet 38 2006 904 909 (Pubitemid 44141658)
21. J. Fellay, A.J. Thompson, D. Ge, C.E. Gumbs, T.J. Urban, and K.V. Shianna ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C Nature 464 2010 405 408
22. S. Sumi, A.M. Marinaki, M. Arenas, L. Fairbanks, M. Shobowale-Bakre, and D.C. Rees Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency Hum Genet 111 2002 360 367 (Pubitemid 36075062)
23. M. Shipkova, K. Lorenz, M. Oellerich, E. Wieland, and N. von Ahsen Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population Clin Chem 52 2006 240 247 (Pubitemid 43185485)
24. T. Maeda, S. Sumi, A. Ueta, Y. Ohkubo, T. Ito, and A.M. Marinaki Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency in the Japanese population Mol Genet Metab 85 2005 271 279 (Pubitemid 41074110)
25. S. Atanasova, M. Shipkova, D. Svinarov, A. Mladenova, M. Genova, and E. Wieland Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6 Ther Drug Monit 29 2007 6 10 (Pubitemid 46279870)
26. T. Poynard, P. Marcellin, S.S. Lee, C. Niederau, G.S. Minuk, and G. Ideo Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) Lancet 352 1998 1426 1432 (Pubitemid 28510876)
27. G.L. Davis, R. Esteban-Mur, V. Rustgi, J. Hoefs, S.C. Gordon, and C. Trepo Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group N Engl J Med 339 1998 1493 1499 (Pubitemid 28543497)
28. A.J. Thompson, A.J. Muir, M.S. Sulkowski, D. Ge, J. Fellay, and K.V. Shianna Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus Gastroenterology 139 2010 120 129 e118
29. A.I. Schafer Thrombocytosis N Engl J Med 350 2004 1211 1219 (Pubitemid 38339365)
30. J.E. Cardier, C.L. Erickson-Miller, and M.J. Murphy Jr. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions Stem Cells 15 1997 286 290 (Pubitemid 27315332)
31. V.C. Broudy, N.L. Lin, and K. Kaushansky Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro Blood 85 1995 1719 1726
32. M. Honda, A. Sakai, T. Yamashita, Y. Nakamoto, E. Mizukoshi, and Y. Sakai Hepatic ISG expression is associated with genetic variation in IL28B and the outcome of IFN therapy for chronic hepatitis C Gastroenterology 139 2010 499 509
33. T.J. Urban, A.J. Thompson, S.S. Bradrick, J. Fellay, D. Schuppan, and K.D. Cronin IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C Hepatology 52 2010 1888 1896
34. S.E. Doyle, H. Schreckhise, K. Khuu-Duong, K. Henderson, R. Rosler, and H. Storey Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes Hepatology 44 2006 896 906 (Pubitemid 46489554)
35. C. Sommereyns, S. Paul, P. Staeheli, and T. Michiels IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo PLoS Pathog 4 2008 e1000017
36. A.J. Muir, M.L. Shiffman, A. Zaman, B. Yoffe, A. de la Torre, and S. Flamm Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection Hepatology 52 3 2010 822 832